Neurophysiologic study of central pain in patients with Parkinson disease

Neurology

Volumn 69, Issue 23, 2007, Pages 2162-2169

  Schestatsky, P ^a   Kumru, H ^b   Valls Sole J ^c,e   Valldeoriola, F ^c   Marti, M J ^c   Tolosa, E ^c   Chaves, M L ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b University Institute affiliated with the Autonomous University of Barcelona   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CONDUCTANCE; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; HABITUATION; HEAT SENSITIVITY; HUMAN; HYPERALGESIA; LASER; MALE; NEUROPHYSIOLOGY; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SENSORY ANALYSIS; SWEATING;

EID: 37349102364     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000295669.12443.d3     Document Type: Article

References (53)

1. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology 1976;26:423-429.
2. Koller WC. Sensory symptoms in Parkinson's disease. Neurology 1984;34:957-959.
3. Ford B. Pain in Parkinson's disease. Clin Neurosci 1998;5:63-72.
4. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:822-825.
5. Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain 1995;60:3-38.
6. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004;62:2171-2175.
7. Merskey H, Bogduk N, eds. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Seattle : IASP Press; 1994:209-212.
8. Bogousslavsky J, Regli F, Uske A. Thalamic infarcts: clinical syndromes, etiology, and prognosis. Neurology 1988;38:837-848.
9. Rousseaux M, Cassim F, Bayle B, Laureau E. Analysis of the perception of and reactivity to pain and heat in patients with Wallenberg syndrome and severe spinothalamic tract dysfunction. Stroke 1999;10:2223-2229.
10. Defrin R, Ohry A, Blumen N, Urca G. Characterization of chronic pain and somatosensory function in spinal cord injury subjects. Pain 2001;89:253-263.
11. Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005;114:473-481.
12. Ducreux D, Attal N, Parker F, Bouhassira D. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain 2006;129:963-976.
13. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of L-dopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005;20:1557-1563.
14. Lindvall O, Bjorklund A, Skagerberg G. Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol 1983;14:255-260.
15. Bromm B, Treede RD. Human cerebral potentials evoked by CO2 laser stimuli causing pain. Exp Brain Res 1987;67:153-162.
16. Treede RD, Lorenz J, Baumgartner U. Clinical usefulness of laser-evoked potentials. Neurophysiol Clin 2003;33:303-314.
17. Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004;11:153-162.
18. Veciana M, Valls-Solé J, Schestatsky P, Montero J, Casado V. Abnormal sudomotor skin responses to temperature and pain stimuli in syringomyelia. J Neurol 2007;254:638-645.
19. Casey KL, Beydoun A, Boivie J, et al. Laser-evoked cerebral potentials and sensory function in patients with central pain. Pain 1996;64:485-491.
20. Garcia-Larrea L, Convers P, Magnin M, et al. Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain. Brain 2002;125:2766-2781.
21. Bingel U, Quante M, Knab R, Bromm B, Weiller C, Buchel C. Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 2002;99:313-321.
22. Cervera A, Veciana M, Valls-Solé J. Sympathetic sudomotor skin responses induced by laser stimuli in normal human subjects. Neurosci Lett 2002;334:115-118.
23. Rossi P, Truini A, Serrao M, et al. Sympathetic skin response evoked by laser skin stimulation. Funct Neurol 2002;17:129-132.
24. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
25. Johnsen B, Fuglsang-Frederiksen A. Electrodiagnosis of polyneuropathy. Neurophysiol Clin 2000;30:339-351.
26. Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve 2004;29:734-747.
27. Claus D, Schondorf R. Sympathetic skin response. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999;52:277-282.
28. Truini A, Galeotti F, Romaniello A, Virtuoso M, Iannetti GD, Cruccu G. Laser-evoked potentials: normative values. Clin Neurophysiol 2005;116:821-826.
29. Boivie J. Central pain and the role of quantitative sensory testing (QST) in research and diagnosis. Eur J Pain 2003;7:339-343.
30. Boivie J, Leijon G, Johansson I. Central post-stroke pain: a study of the mechanisms through analyses of the sensory abnormalities. Pain 1989;37:173-185.
31. Scott DJ, Heitzeg MM, Koeppe RA, Stohler CS, Zubieta JK. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci 2006;26:10789-10795.
32. de Tommaso M, Losito L, Libro G, et al. Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack. Cephalalgia 2005;25:359-368.
33. Cruccu G, Leandri M, Iannetti GD, et al. Small-fiber dysfunction in trigeminal neuralgia: carbamazepine effect on laser-evoked potentials. Neurology 2001;56:1722-1726.
34. Wager TD, Matre D, Casey KL. Placebo effects in laser-evoked potentials. Brain Behav Immun 2006;20:219-230.
35. Slaoui T, Mas-Gerdelat A, Ory-Magne F, Rascol O, Brefel-Courbon C. Levodopa modifies pain thresholds in Parkinson's disease patients. Rev Neurol 2007;163:66-71.
36. Ertas M, Sagduyu A, Arac N, Uludag B, Ertekin C. Use of L-dopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1998;75:257-259.
37. Kernbaum S, Hauchecorne J. Administration of L-dopa for relief of herpes zoster pain. JAMA 1981;246:132-134.
38. Nixon DW. Use of L-dopa to relieve pain from bone metastases. N Engl J Med 1975;292:647.
39. Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 2006;32:462-469.
40. Buzas B, Max M. Pain in Parkinson's disease. Neurology 2004;62:2156-2157.
41. Urakami K, Takahashi K, Matsushima E, Sano K, Nishikawa S, Takao T. The threshold of pain and neurotransmitter's change on pain in Parkinson's disease. Jpn J Psychiatry Neurol 1990;44:589-593.
42. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-1964.
43. Petrovic P, Petersson KM, Hansson P, Ingvar M. Brain-stem involvement in the initial response to pain. Neuroimage 2004;22:995-1000.
44. Benarroch EE. Pain-autonomic interactions. Neurol Sci 2006;27:S130-S133.
45. Rainville P, Bao QV, Chretien P. Pain-related emotions modulate experimental pain perception and autonomic responses. Pain 2005;118:306-318.
46. Zambreanu L, Wise RG, Brooks JC, Iannetti GD, Tracey I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain 2005;114:397-407.
47. Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997;14:2-31.
48. Braak H, Del Tredici K, Rüb U, de Vos RAI, Steur E, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
49. Flores JA, El Banousa F, Galán-Rodriguez B, Ferndandez-Espejo E. Opiate anti-nociception following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 2004;110:205-204.
50. Lu L, Neff F, Fischer DA, et al. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects. Neurobiol Dis 2006;23:409-421.
51. Diatchenko L, Nackley AG, Slade GD, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-224.
52. Klossika I, Flor H, Kamping S, et al. Emotional modulation of pain: a clinical perspective. Pain 2006;124:264-268.
53. Guinjoan SM, Bernabo JL, Cardinali DP. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry 1995;59:299-302.